Mast Therapeutics Price Prediction

Mast Therapeutics Inc -- USA Stock  

USD 0.13  0.0089  6.36%

Macroaxis is not in business of monitoring Mast Therapeutics headlines and social sentiment data; there are plenty of companies out there that do it quite successfully. However, we do analyze noise-free headlines and recent hype associated with Mast Therapeutics Inc brand which may create opportunities for some arbitrage if properly timed. With Mast Therapeutics hype-based prediction module you can estimate the value of Mast Therapeutics Inc from the prospective of Mast Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on Mast Therapeutics over a specific investment horizon. Please see also Stocks Correlation.
 Time Horizon     30 Days    Login   to change

Mast Therapeutics Estimiated After-Hype Price Volatility

 Next price density 
Expected price to next headline
February 19, 2018
Current Value
Downside upside
After-hype Price
Target Price Odds
 Above  Below  
Upside upside
Mast Therapeutics is Unknown risk asset. Analysis and calculation of next after-hype price of Mast Therapeutics Inc is based on 1 month time horizon.

Mast Therapeutics Hype Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.00% 0.00% 0.00%  0.00% 0 Events / Month1 Events / MonthUncertain
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Mast Therapeutics Hype Timeline

Mast Therapeutics Inc is now traded for0.13. This company stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Mast Therapeutics Inc is projected not to react to the next headline with price going to stay at about the same level and average media hype impact volatility of 0.0%. The immediate return on the next news is projected to be very small where as daily expected return is now at 0.0%. The volatility of relative hype elasticity to Mast Therapeutics is about 0.0%%. The volatility of related hype on Mast Therapeutics is about 0.0% with expected price after next announcement by competition of 0.13. About 23.0% of the company shares are owned by institutional investors. The company recorded loss per share of 0.17. Mast Therapeutics Inc had not issued any dividends in recent years. This company had 1:25 split on April 26, 2010. Given the investment horizon of 30 days, the next projected press release will be uncertain.
Please see also Stocks Correlation.

Mast Therapeutics Related Hype Analysis